Journal of Pharmacology and Pharmacotherapeutics volume 16, issue 2 cover
Search this issue

Cover: Journal of Pharmacology and Pharmacotherapeutics

Journal of Pharmacology and Pharmacotherapeutics

Volume 16, Issue 2

2025 · pp. 129–243 · 11 articles

Volume
16
Issue
2
Published
2025
Pages
129–243
Articles
11
Sections
3
ISSN
Print - 0976-500X, Online - 0976-5018
Journal
JPP

In this issue

Review Article

  1. Review

    Mohammed K. Alshammari, Hind M. Al Osaimi, Norah F. Alshehri, Raneem F. Masoud, Alaa O. Abdulaal, Bashair Z. Al Qaidi

    pp. 129–142 · DOI: 10.1177/0976500X241303306 · 2025

    Background: Pediatric wellbeing and health outcomes are among the leading indicators of World Health Organization (WHO). Growing infections and risk of antibiotic resistance have appeared to be one of the main cause if m…

  2. Review

    Aditya Kumar Bubna, Vinayak Viplav

    pp. 143–163 · DOI: 10.1177/0976500X241303186 · 2025

    Background: Apremilast is a phosphodiesterase-4 (PDE-4) inhibitor approved by the US-Food and Drug Administration (US-FDA) for the management of adult patients with plaque psoriasis (who are candidates for phototherapy/s…

  3. Review

    Nagaraju Bandaru, Mohan Gandhi Bonthu, Alluri Pavani Gayatri, Shashikala Metri, Perli Kranti Kumar, Aneesha Addanki, Srilaksmi Nallapaty, Karri Swathi Priya, Dodda Tulase Nadhreddy, P. N. S. Gowravi

    pp. 164–171 · DOI: 10.1177/0976500X241312726 · 2025

    Background: Alzheimer’s disease (AD) is a complex neurological disorder characterized by neuronal loss and progressive cognitive decline. The disease progression is influenced by both environmental and genetic factors. R…

Original Research Article

  1. Article

    Nitya Krishnasamy, Ramya Ramadoss, Kochli Channapa Niranjan, Vikram S Amberkar, Haris Chandra Sahoo, Poorna Devadoss

    pp. 172–184 · DOI: 10.1177/0976500X241299231 · 2025

    Background: Oral squamous cell carcinoma (OSCC) is a prevalent form of head and neck cancer characterized by aggres-sive behavior and a poor prognosis. Conventional therapies have demonstrated limited effectiveness, unde…

  2. Article

    Patrick A. Kalona, Uma Sundaresan, Chellappandian Muthiah, Ariharasivakumar Ganesan

    pp. 185–192 · DOI: 10.1177/0976500X241299159 · 2025

    Background: Cyclophosphamide is one of the most extensively used chemotherapeutic drugs and is employed to treat several malignancies. Cyclophosphamide often comes with several unpleasant side effects. The primary negati…

  3. Article

    Ajay Gattani, Komal Khurade, Raakhi Tripathi, Rajmohan Seetharaman, Sharmila Jalgaonkar

    pp. 193–201 · DOI: 10.1177/0976500X241299162 · 2025

    Background: Animal models play a critical role in biomedical research, yet comprehensive data on the types and distribution of animals used in different research contexts are sparse. Objectives: This study aims to provid…

  4. Article

    Aashish Joshi, Kailash Karande, Ravindra Gunaki

    pp. 202–213 · DOI: 10.1177/0976500X241303572 · 2025

    Background: Accidents are the major reasons causing hip bone fractures. These are due to reduced bone density due to aging effect which may cause fractures typically in proximal part of the femur bone. Objectives: The pu…

  5. Article

    Mohammed Kanan, Abdullah Almotairi, Faisal Alrumaih, Reem Hammad, Mohammed Almotairi

    pp. 214–225 · DOI: 10.1177/0976500X241303618 · 2025

    Background: Bone marrow transplantation (BMT) is a crucial treatment for pediatric patients with various hematological, oncological, and genetic diseases. However, persistent thrombocytopenia (PT) post-transplantation po…

  6. Article

    Akella Krishna Sowmya, Sunil Kumar Pandey

    pp. 226–233 · DOI: 10.1177/0976500X241305442 · 2025

    Background: Mental health issues in children and adolescents are quite significant. Despite their impact, research on psychiatric disorders in these age groups is limited. This study aims to evaluate the prescription pat…

  7. Article

    Visha MG, Deepak Moses Ravindran, Balaji SK, Lekha Ashokkumar

    pp. 234–242 · DOI: 10.1177/0976500X241306178 · 2025

    Background: Periodontal disease is a chronic inflammatory disease that activates the innate immune response. Activation of the TREM-1 signaling pathway promotes the synthesis of inflammatory cytokines like interleukin-1 …

Erratum

  1. Article

    pp. 243–243 · DOI: 10.1177/0976500X251319617 · 2025